SCHEMBL26908807

SCHEMBL26908807

Cc1ccc(CN2CCN(CC=O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.54
▸ POLB P06746 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ FAAH O00519 1/20 0.49
▸ ATM Q13315 2/20 0.49
▸ GAA P10253 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CASP3 P42574 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19605877 0.90 LMNA (0.66) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL19403152 0.90 LMNA (0.66) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL15363580 0.90 LMNA (0.66) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL15694257 0.87 ITGB3 (0.48) LMNASMN1; SMN2ALDH1A1KDM4EMAPK1
SCHEMBL26316648 0.84 HRH3 (0.61) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL23977354 0.83 LMNA (0.60) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL13336270 0.83 KDM4E (0.43) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL24115228 0.82 LMNA (0.55) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL18807607 0.81 LMNA (0.39) LMNAPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL5538919 0.78 HSD17B10 (0.48) SMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3925952-B1 PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER UNIV JOHNS HOPKINS (US) 2023-11-29 — — EP disclosed
Send feedback